Medicenna Therapeutics (MDNA) Competitors C$0.84 0.00 (0.00%) As of 08/1/2025 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider TradesBuy This Stock MDNA vs. FRX, ITH, IPA, CRDL, APM, GXE, GPH, WMD, EQ, and SGWShould you be buying Medicenna Therapeutics stock or one of its competitors? The main competitors of Medicenna Therapeutics include Fennec Pharmaceuticals (FRX), International Tower Hill Mines (ITH), ImmunoPrecise Antibodies (IPA), Cardiol Therapeutics (CRDL), Andean Precious Metals (APM), Gear Energy (GXE), Graphite One (GPH), WeedMD (WMD), EQ (EQ), and Shoal Games (SGW). These companies are all part of the "pharmaceutical products" industry. Medicenna Therapeutics vs. Its Competitors Fennec Pharmaceuticals International Tower Hill Mines ImmunoPrecise Antibodies Cardiol Therapeutics Andean Precious Metals Gear Energy Graphite One WeedMD EQ Shoal Games Medicenna Therapeutics (TSE:MDNA) and Fennec Pharmaceuticals (TSE:FRX) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, profitability, dividends, risk and analyst recommendations. Is MDNA or FRX more profitable? Fennec Pharmaceuticals has a net margin of -2.30% compared to Medicenna Therapeutics' net margin of -533,640.00%. Fennec Pharmaceuticals' return on equity of 29.94% beat Medicenna Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Medicenna Therapeutics-533,640.00% -159.88% -32.80% Fennec Pharmaceuticals -2.30%29.94%8.88% Which has more risk and volatility, MDNA or FRX? Medicenna Therapeutics has a beta of 1.21, meaning that its share price is 21% more volatile than the S&P 500. Comparatively, Fennec Pharmaceuticals has a beta of 0.25, meaning that its share price is 75% less volatile than the S&P 500. Do analysts prefer MDNA or FRX? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Medicenna Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Fennec Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00 Which has stronger earnings & valuation, MDNA or FRX? Fennec Pharmaceuticals has higher revenue and earnings than Medicenna Therapeutics. Fennec Pharmaceuticals is trading at a lower price-to-earnings ratio than Medicenna Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMedicenna TherapeuticsC$4.87K12,908.72-C$25.98M-C$0.36-2.31Fennec PharmaceuticalsC$34.86M6.09-C$800.44K-C$0.06-186.51 Does the media prefer MDNA or FRX? In the previous week, Medicenna Therapeutics' average media sentiment score of 0.00 equaled Fennec Pharmaceuticals'average media sentiment score. Company Overall Sentiment Medicenna Therapeutics Neutral Fennec Pharmaceuticals Neutral Do insiders & institutionals have more ownership in MDNA or FRX? 13.0% of Medicenna Therapeutics shares are held by institutional investors. Comparatively, 52.8% of Fennec Pharmaceuticals shares are held by institutional investors. 22.6% of Medicenna Therapeutics shares are held by company insiders. Comparatively, 16.2% of Fennec Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. SummaryFennec Pharmaceuticals beats Medicenna Therapeutics on 9 of the 13 factors compared between the two stocks. Get Medicenna Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for MDNA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MDNA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MDNA vs. The Competition Export to ExcelMetricMedicenna TherapeuticsBiotechnology IndustryMedical SectorTSE ExchangeMarket CapC$62.85MC$134.51MC$5.49BC$6.20BDividend YieldN/A3.74%4.73%6.72%P/E Ratio-2.313.8128.8663.43Price / Sales12,908.724,246.60371.481,250.99Price / Cash1.1513.1935.4583.29Price / Book3.2239.388.274.86Net Income-C$25.98M-C$90.99MC$3.25BC$301.20M7 Day PerformanceN/A-1.84%-3.73%-2.27%1 Month Performance-3.45%11.20%4.29%0.79%1 Year Performance-62.83%189.79%25.87%26.62% Medicenna Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MDNAMedicenna TherapeuticsN/AC$0.84flatN/A-63.2%C$62.85MC$4.87K-2.3120FRXFennec PharmaceuticalsN/AC$11.74-2.1%N/A+27.4%C$226.40MC$34.86M-198.8710Gap DownITHInternational Tower Hill MinesN/AC$1.61+14.2%N/A+151.6%C$226.04MN/A-67.26220News CoverageGap UpHigh Trading VolumeIPAImmunoPrecise AntibodiesN/AC$6.50+0.8%N/A+0.0%C$162.08MC$19.47M-7.3080Gap DownCRDLCardiol TherapeuticsN/AC$1.95+3.7%N/A-34.1%C$161.81MN/A-3.8320APMAndean Precious Metals2.3913 of 5 starsC$1.29+7.5%C$2.00+55.0%+26.5%C$135.47MC$154.78M2.5530Positive NewsGXEGear EnergyN/AN/AN/AN/AC$126.52MC$134.93M10.391,310GPHGraphite OneN/AC$1.12+9.8%N/A+9.2%C$113.41MN/A-16.1020Gap UpHigh Trading VolumeWMDWeedMDN/AC$0.28-1.8%N/A+0.0%C$67.82MC$27.53M-0.66628Gap UpEQEQN/AC$0.97flatN/A-11.0%C$67.51MC$9.70M-14.4840News CoverageGap DownHigh Trading VolumeSGWShoal GamesN/AC$0.50+42.9%N/A+0.0%C$65.56MC$106.98K-12.5040Gap Up Related Companies and Tools Related Companies Fennec Pharmaceuticals Alternatives International Tower Hill Mines Alternatives ImmunoPrecise Antibodies Alternatives Cardiol Therapeutics Alternatives Andean Precious Metals Alternatives Gear Energy Alternatives Graphite One Alternatives WeedMD Alternatives EQ Alternatives Shoal Games Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:MDNA) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersWhy Elon put $51 million into thisA single U.S. company has started producing a “miracle metal” once locked in research labs. Now? They’re qu...True Market Insiders | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medicenna Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medicenna Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MDNA Stock Alerts